ReviewFrontiers in oncology2016
Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination.
Review in Frontiers in oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 63 citations in OpenAlex.
- Human papillomavirus vaccination at age 9 or 10 years to increase coverage - a narrative review of the literature, United States 2014-2024.Human vaccines & immunotherapeutics · 2025Pooled it
- Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis.Medicine · 2022Pooled it
- The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.Medicine · 2017Pooled it
- Cultural barriers and facilitators of the parents for human papillomavirus (HPV) vaccination uptake by their daughters: A systematic review.Jornal de pediatriaPooled it
- The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review.Journal of family medicine and primary care · 2024Review
- Extended HPV typing test performed better predict value for CIN2+ among elderly women in China.Preventive medicine reports · 2024Article
- HPV and HPV Vaccine Awareness Among African Americans in the Black Belt Region of Alabama.Journal of racial and ethnic health disparities · 2024Article
- Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients.Frontiers in oncology · 2024Article
- Article
- Awareness about Human Papillomavirus Vaccine and Its Uptake among Women from North India: Evidence from a Cross-Sectional Study.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- The cancer epidemic in the Caribbean region: Further opportunities to reverse the disease trend.Lancet regional health. Americas · 2022Review
- The Role of Healthcare Providers in Promoting Human Papillomavirus Vaccines among Men Who Have Sex with Men: A Scoping Review.Vaccines · 2022Article
- Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South.Cancers · 2021Article
- Diverse caregivers' HPV vaccine-related awareness and knowledge.Ethnicity & health · 2021Article
- HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study.Human vaccines & immunotherapeutics · 2021Article
- Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.BMC public health · 2020Article
- Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA.Journal of cancer education : the official journal of the American Association for Cancer Education · 2019Article
- Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).Vaccine · 2019Article
- Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.Human vaccines & immunotherapeutics · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) vaccination rates for preadolescent and adolescent girls in the United States are far behind those of other developed nations. These rates differ substantially by region and state, socioeconomic status, and insurance status. In parents and young women, a lack of awareness and a misperception of the risk of this vaccine drive low vaccination rates. In physicians, lack of comfort with discussion of sexuality and the perception that the vaccine should be delayed to a later age contribute to low vaccination rates. Patient- and physician-targeted educational campaigns, systems-based interventions, and school-based vaccine clinics offer a variety of ways to address the barriers to HPV vaccination. A diverse and culturally appropriate approach to promoting vaccine uptake has the potential to significantly improve vaccination rates in order to reach the Healthy People 2020 goal of over 80% vaccination in adolescent girls. This article reviews the disparities in HPV vaccination rates in girls in the United States, the influences of patients', physicians', and parents' attitudes on vaccine uptake, and the proposed interventions that may help the United States reach its goal for vaccine coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.